<table xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (<linkhtml href="#i4i_section_id_4c210bb6-d54d-4eca-9561-1936a1800edc">2.6</linkhtml>, <linkhtml href="#i4i_section_id_18601f6d-a250-4ab8-81a0-e32d156027dc">5.1</linkhtml>, <linkhtml href="#i4i_interactions_id_01adda29-964c-40a9-9a2a-acacf3b3d4b2">7</linkhtml>, <linkhtml href="#i4i_pharmacokinetics_id_36336745-ec10-451c-b03c-c6f908162f22">12.3</linkhtml>) </caption>
<col width="54%"></col>
<col width="62%"></col>
<tbody>
<tr>
<td stylecode="Botrule Lrule Toprule ">
<paragraph>Interacting Agents </paragraph>
</td>
<td stylecode="Rrule Botrule Lrule Toprule ">
<paragraph>Prescribing Recommendations </paragraph>
</td>
</tr>
<tr>
<td stylecode="Lrule Botrule ">
<paragraph>Cyclosporine, HIV protease inhibitors (tipranavir plus ritonavir), hepatitis C protease inhibitor (telaprevir)</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>Avoid atorvastatin </paragraph>
</td>
</tr>
<tr>
<td stylecode="Lrule Botrule ">
<paragraph>HIV protease inhibitor (lopinavir plus ritonavir)</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>Use with caution and lowest dose necessary</paragraph>
</td>
</tr>
<tr>
<td stylecode="Lrule Botrule ">
<paragraph>Clarithromycin, itraconazole, HIV protease inhibitors (saquinavir plus ritonavir, darunavir plus ritonavir, fosamprenavir, fosamprenavir plus ritonavir)</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>Do not exceed 20 mg atorvastatin daily</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Botrule Lrule Toprule ">
<paragraph>HIV protease inhibitor (nelfinavir)</paragraph>
<paragraph>Hepatitis C protease inhibitor (boceprevir) </paragraph>
</td>
<td stylecode="Rrule Botrule Lrule Toprule ">
<paragraph>Do not exceed 40 mg atorvastatin daily</paragraph>
</td>
</tr>
</tbody>
</table>